Resources Contact Us Home
Formulation of quinazoline based EGFR inhibitors containing a zinc binding moiety

Image Number 13 for United States Patent #8119616.

The present invention relates to a composition comprising an inclusion complex of a cyclodextrin and quinazoline containing zinc-binding moiety based derivatives. The cyclodextrin is preferable a .beta.-cyclodextrin or a derivative thereof. The quinazolines have enhanced and unexpected properties as inhibitors of epidermal growth factor receptor tyrosine kinase (EGFR-TK) and their use in the treatment of EGFR-TK related diseases and disorders such as cancer. The said derivatives may further act as HDAC inhibitors.

  Recently Added Patents
Semiconductor fin device and method for forming the same using high tilt angle implant
Receiving security risk feedback from linked contacts due to a user's system actions and behaviors
Field-programmable analog array with memristors
Cylindrical lithium secondary battery comprising a contoured center pin
Transferring data by touch between touch-screen devices
Information storage medium, reproducing method, and recording method
Manufacturing aircraft parts
  Randomly Featured Patents
Process for the lost foam casting, under low pressure, of aluminium alloy articles
Nephrolepis plant named `Sunjest`
Enhanced products and processes for removing cavity tissue
Process for forming a thin film of TiSiN, in particular for phase change memory devices
MRI image enchancement of bone and related tissue using complexes of paramagnetic cations and polyphosphonate ligands
Sputtering using an unbalanced magnetron
Kitchen faucet
Method and apparatus for controlling air-fuel ratio in an internal combustion engine by corrective feedback control
Carding flat structure
Turfplaner with autograde and autodepth